Product Banner

Clinical trials Market in India 2014

Clinical trials Market in India 2014

* Required Fields

  • Jul 22, 2014
  • 77 pages
  • Netscribes
Netscribes' latest market research report titled Clinical Trials Market in India 2014 analyses how India is a potential global hub for conducting clinical trials by Indian as well as global pharmaceutical companies. Clinical trials are conducted on humans to examine the efficacy and safety of new drugs, treatments, therapies and new medical devices before launching them in the market. It is a necessary and final step for the completion of the drug development process. The market is divided into four phases - Phase I, Phase II, Phase III and Phase IV. Contract Research Organizations (CROs) are responsible for designing, monitoring, and managing clinical trials. The market is dominated by private players and foreign pharmaceutical companies.
The clinical research market in India has comparative advantage in conducting clinical trials regarding cost efficiency and a vast population suffering from acute chronic diseases. Government regulations regarding the compensation rule and approval time are hampering the market at present, but the situation is expected to improve soon. Apart from the pharma companies there are several research institutes involved in R&D of clinical trials. Increasing partnerships and changes in the regulatory environment are crucial future driving factors for this market.
Table of Contents
Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Aug 2013 - Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Slide 5: Clinical Trials - Drug Development Overview
Slide 6: Clinical Trials - Role of Contract Research Organizations

Market Overview
Slide 7: Clinical Trials - Global Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 8: Clinical Trials - Market Overview, and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 9: Clinical Trials - Overview of Clinical Trials Registered, Cost of conducting Clinical Trials and Distribution of Clinical Trials according to therapeutic areas
Slide 10: Clinical Trials - Distribution of Clinical Trials on the basis phase and Overview of Pharmaceutical Companies conducting Clinical Trials

Drivers & Challenges
Slide 11: Clinical Trials - Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-19: Challenges

Government Participation
Slide 20: Classification of Clinical Trials for the purpose of approval
Slide 21: Overview of the Schedule Y of the Drugs and Cosmetics Act
Slide 22: Overview of the amendments in Schedule Y
Slide 23: Overview of the ICMR guidelines

Competitive Landscape
Clinical Research Organizations
Slide 24: Porter's Five Forces Analysis
Slide 25-28: Competitive Benchmarking (FY 2013)
Slide 29-68: Major Private Players

Clinical Research Institutes
Slide 69-71: Major Research Organizations

Recent Developments
Slide 72: Recent Developments

Strategic Recommendations
Slide 73-75: Strategic Recommendations

Slide 76-77: Ratio and Calculations and Secondary Research
List of Figures
Macro Economic Indicators
1. GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14)
2. Inflation Rate: Monthly (Jul-Aug 2013 - Nov-Dec 2013)
3. Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013)
4. Exchange Rate: Monthly (Aug 2013 - Mar 2014)
5. Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12)
6. Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13, 2013-14*)
7. FDI Annual (2009-10, 2010-11, 2011-12, 2012-13)

Market Overview
1. CROs Global Market Size and Growth (2013 - 2018e)
2. Share of Human Clinical Trials (2013)
3. Clinical Trials Market Size and Growth (2013-2018e)
4. Number of Trials Registered Each Year (2011-2013)
5. Trials According to Therapeutic Areas (2013)
6. Distribution of trials on the basis of Phase (2013)
7. Share of Pharma Companies Conducting Trials (2013)

Drivers & Challenges
1. Prevalence of Chronic Lifestyle Diseases in India (2011 - 2016e)
2. Research and Development Spending (2011-2012 -2012-2013)
3. Market Size and Growth of Private Hospitals (2012 - 2018e)
4. Clinical Trials Approval Time (2013)

Competitive Landscape
1. Competitive Benchmarking - Key Ratios of 3 Major Private Companies - Operational & Financial Basis (FY2013)

2. Company Profiles (All Companies)
a. Ownership Structure (Private Companies)
List of Tables
Market Overview
1. Average Cost of Clinical Trial in India
2. Major Pharma Companies Sponsoring Trials

Drivers & Challenges
1. Clinical Research Project Management Services in India
2. Amount of Compensation for Clinical Trial Participants in India

Government Participation
1. Amendments to Drugs and Cosmetics Rule (DCR) 1945

Competitive Landscape
1. Company Profiles (All Companies)
a. Company Information (All Companies)
b. Products and Services (All Companies)
c. Key People (All Companies)
d. Shareholders of the Company (Private Companies)
e. Key Ratios (All Companies)
f. Business Highlights (All Companies)
2. Clinical Research Institutes

Recent Developments
1. Key Developments


1. Ratio Calculations
2. Secondary Research
Companies Covered
Private Companies
1. Clininvent Research Pvt. Ltd.
2. SIRO Clinpharm Pvt. Ltd.
3. Sristek Clinical Research Solutions Ltd.
4. Synchron Research Services Pvt. Ltd.
5. Clintech Research India Pvt. Ltd.
6. ICON Clinical Research India Pvt. Ltd.
7. PAREXEL International (India) Pvt. Ltd.
8. Quintiles Research (India) Pvt. Ltd.

Research Organizations
1. Advanced Centre for Treatment, Research and Education in Cancer
2. Central Drug Research Institute (CDRI)
3. Institute of Cytology & Preventive Oncology
4. National AIDS Research Institute
5. National Brain Research Center
6. National Institute of Cholera and Enteric Diseases
7. National Institute of Immunology
8. National Institute of Nutrition
9. National Institute of Virology (NIV)
10. Tuberculosis Research Centre (TRC)